Literature DB >> 8527749

[Bronchiectasis and infection incidence in alpha 1-antitrypsin deficiency. The value of high-resolution computed tomography].

H U Kauczor1, A Hoffmann, H Mehdikhani, K Schunk, J Schlegel, P Mildenberger.   

Abstract

UNLABELLED: PURPOSE of this study was to determine the prevalence of bronchiectasis in patients suffering from alpha-1-antitrypsin deficiency and to compare its extent with the frequency of infections.
MATERIAL AND METHODS: High-resolution CT examinations (HRCT) of 23 patients with alpha-1-antitrypsin deficiency were retrospectively assessed for extent, severity and localisation of bronchiectasis, bronchial wall thickening and extent of emphysema. Chest radiographs and clinical records were available for correlation.
RESULTS: HRCT scans showed bronchiectasis in 14 of 23 patients, bronchial wall thickening in 3/14, and panlobular emphysema in 23/23. Chest radiographs showed bronchiectasis in 4/23 patients. Only two of 9 patients without bronchiectasis had a history of infections; all 8 patients with multiple bronchiectasis had a history of recurrent infections.
CONCLUSION: Bronchiectasis is a common finding in alpha-1-antitrypsin deficiency, and is associated with recurrent infections. HRCT is superior to chest radiography as an indicator for the risk of infection in these patients.

Entities:  

Mesh:

Year:  1995        PMID: 8527749     DOI: 10.1055/s-2007-1016012

Source DB:  PubMed          Journal:  Rofo        ISSN: 1438-9010


  2 in total

Review 1.  Severe bronchiectasis.

Authors:  Brian M Morrissey; Samuel J Evans
Journal:  Clin Rev Allergy Immunol       Date:  2003-12       Impact factor: 8.667

2.  Results from a large targeted screening program for alpha-1-antitrypsin deficiency: 2003 - 2015.

Authors:  Timm Greulich; Christoph Nell; Christian Herr; Claus Vogelmeier; Viktor Kotke; Stefan Wiedmann; Marion Wencker; Robert Bals; Andreas Rembert Koczulla
Journal:  Orphanet J Rare Dis       Date:  2016-06-10       Impact factor: 4.123

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.